Engene announces the resignation of its chief medical officer

Boston & montreal--(business wire)--engene holdings inc. (nasdaq: engn or “engene” or the “company”), a clinical-stage, non-viral genetic medicines company, announced today that dr. raj pruthi resigned from his role as chief medical officer on june 3, 2025. dr. pruthi's resignation as chief medical officer will take effect on june 16, 2025. he will be supporting the organization to ensure an orderly transition of his responsibilities before he departs. the company intends to reallocate dr. prut.
ENGN Ratings Summary
ENGN Quant Ranking